Technical Analysis for AYLA - Ayala Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Up |
| Historical AYLA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Narrow Range Bar | Range Contraction | 4.05% | |
| NR7 | Range Contraction | 4.05% | |
| NR7-2 | Range Contraction | 4.05% | |
| NR7 | Range Contraction | 4.53% | |
| NR7-2 | Range Contraction | 4.53% | |
| Down 3 Days in a Row | Weakness | 4.53% | |
| NR7 | Range Contraction | 4.18% | |
| Hot IPO Pullback | Bullish Swing Setup | 2.82% | |
| Hot IPO Pullback | Bullish Swing Setup | 3.36% | |
| New 52 Week Closing High | Bullish | -1.44% |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: ???
- Sector: Healthcare
- Industry: Biotechnology
Ayala Pharmaceuticals, Inc. is a clinical-stage oncology. It is focused on the development and commercialization of small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Wilmington, DE.
Medicine Biotechnology Clinical Medicine Drugs Oncology Drug Development Medical Tests Targeted Therapy Precision Medicine Biomarker
Medicine Biotechnology Clinical Medicine Drugs Oncology Drug Development Medical Tests Targeted Therapy Precision Medicine Biomarker
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 16.5 |
| 52 Week Low | 14.63 |
| Average Volume | 75,347 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 0.00 |
| 10-Day Moving Average | 15.32 |
| Average True Range | 0.59 |
| ADX | 0.0 |
| +DI | 21.31 |
| -DI | 7.66 |
| Chandelier Exit (Long, 3 ATRs ) | 14.74 |
| Chandelier Exit (Short, 3 ATRs ) | 16.39 |
| Upper Bollinger Band | 0.00 |
| Lower Bollinger Band | 0.00 |
| Percent B (%b) | 0.0 |
| BandWidth | 0.00 |
| MACD Line | 0.05 |
| MACD Signal Line | 0.00 |
| MACD Histogram | 0.0477 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 16.29 | ||||
| Resistance 3 (R3) | 16.33 | 16.16 | 16.19 | ||
| Resistance 2 (R2) | 16.16 | 16.01 | 16.15 | 16.16 | |
| Resistance 1 (R1) | 15.93 | 15.92 | 15.85 | 15.89 | 16.12 |
| Pivot Point | 15.76 | 15.76 | 15.72 | 15.75 | 15.76 |
| Support 1 (S1) | 15.53 | 15.61 | 15.45 | 15.49 | 15.26 |
| Support 2 (S2) | 15.36 | 15.52 | 15.35 | 15.22 | |
| Support 3 (S3) | 15.13 | 15.36 | 15.19 | ||
| Support 4 (S4) | 15.09 |
